NOT-DA-21-068: Notice to Extend the Expiration Date for PAR-19-368, "Accelerating the Pace of Drug Abuse Research Using Existing Data (R01 Clinical Trial Optional)"

Notice to Extend the Expiration Date for PAR-19-368, "Accelerating the Pace of Drug Abuse Research Using Existing Data (R01 Clinical Trial Optional)"

Notice Number:

NOT-DA-21-068

Key Dates

Release Date:

August 3, 2021

Related Announcements

PAR-19-368 - Accelerating the Pace of Drug Abuse Research Using Existing Data (R01 Clinical Trial Optional)

Issued by

National Institute on Drug Abuse (NIDA)

National Institute on Alcohol Abuse and Alcoholism (NIAAA)

National Cancer Institute (NCI)

Purpose

The purpose of this notice is to inform interested applicants that the expiration Date for PAR-19-368, "Accelerating the Pace of Drug Abuse Research Using Existing Data (R01 Clinical Trial Optional)" will be extended by one Council round (changes shown in bold italics below). This Funding Opportunity Announcement has been modified to add an additional Application due date of October 5, 2021 (new applications), November 5, 2021 (resubmission applications) and an additional AIDS Application Due Date of January 7, 2022.

Currently Reads:

Part 1. Overview

Key Dates

Expiration Date: Septmeber 8, 2021

Modified to Read:

Part 1. Overview

Key Dates

Expiration Date: January 8, 2022

All other aspects of this FOA remain unchanged.

Inquiries

Please direct all inquiries to:

Marsha F. Lopez, Ph.D., M.H.S
National Institute on Drug Abuse (NIDA)
Telephone: 301-443-6504
Email: [email protected]